{"cited_by_count":1494542,"description":"This cluster of papers focuses on the advancements in lung cancer research, particularly in understanding EGFR and ALK mutations, targeted therapy, resistance mechanisms to tyrosine kinase inhibitors, clinical trials evaluating different treatment regimens, genomic profiling for personalized medicine, and the development of treatment guidelines based on molecular biomarkers. The research also explores the concept of oncogene addiction and its implications for targeted therapies.","display_name":"Lung Cancer Treatments and Mutations","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T10417","wikipedia":"https://en.wikipedia.org/wiki/Lung_cancer"},"field_id":"27","id":"T10417","keywords":[{"display_name":"non-small cell lung cancer","id":"non-small-cell-lung-cancer","score":0.212,"url":"https://openalex.org/keywords/non-small-cell-lung-cancer"},{"display_name":"EGFR tyrosine kinase inhibitors","id":"egfr-tyrosine-kinase-inhibitors","score":0.7213,"url":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors"},{"display_name":"EGFR mutation","id":"egfr-mutation","score":0.6906,"url":"https://openalex.org/keywords/egfr-mutation"},{"display_name":"gefitinib","id":"gefitinib","score":0.5261,"url":"https://openalex.org/keywords/gefitinib"},{"display_name":"erlotinib","id":"erlotinib","score":0.4539,"url":"https://openalex.org/keywords/erlotinib"},{"display_name":"advanced non-small cell lung cancer","id":"advanced-non-small-cell-lung-cancer","score":0.5326,"url":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer"},{"display_name":"osimertinib","id":"osimertinib","score":0.801,"url":"https://openalex.org/keywords/osimertinib"},{"display_name":"EGFR-mutant non-small cell lung cancer","id":"egfr-mutant-non-small-cell-lung-cancer","score":0.8735,"url":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer"},{"display_name":"T790M mutation","id":"egfr-t790m-mutation","score":0.8625,"url":"https://openalex.org/keywords/egfr-t790m-mutation"},{"display_name":"ALK inhibitors","id":"alk-inhibitors","score":0.6642,"url":"https://openalex.org/keywords/alk-inhibitors"},{"display_name":"anaplastic lymphoma kinase","id":"anaplastic-lymphoma-kinase","score":0.4727,"url":"https://openalex.org/keywords/anaplastic-lymphoma-kinase"},{"display_name":"acquired drug resistance","id":"acquired-drug-resistance","score":0.3322,"url":"https://openalex.org/keywords/acquired-drug-resistance"},{"display_name":"crizotinib","id":"crizotinib","score":0.6344,"url":"https://openalex.org/keywords/crizotinib"},{"display_name":"ALK rearrangement","id":"alk-rearrangement","score":0.6452,"url":"https://openalex.org/keywords/alk-rearrangement"},{"display_name":"afatinib","id":"afatinib","score":0.5905,"url":"https://openalex.org/keywords/afatinib"},{"display_name":"L858R mutation","id":"egfr-l858r-mutation","score":0.8253,"url":"https://openalex.org/keywords/egfr-l858r-mutation"},{"display_name":"pemetrexed","id":"pemetrexed","score":0.3042,"url":"https://openalex.org/keywords/pemetrexed"},{"display_name":"ALK-positive non-small cell lung cancer","id":"alk-positive-non-small-cell-lung-cancer","score":0.8394,"url":"https://openalex.org/keywords/alk-positive-non-small-cell-lung-cancer"},{"display_name":"exon 19 deletion","id":"exon-19-deletion","score":0.8777,"url":"https://openalex.org/keywords/exon-19-deletion"},{"display_name":"metastatic non-small cell lung cancer","id":"metastatic-nsclc","score":0.4424,"url":"https://openalex.org/keywords/metastatic-nsclc"},{"display_name":"EGFR tyrosine kinase inhibitor resistance","id":"egfr-tki-resistance","score":0.7452,"url":"https://openalex.org/keywords/egfr-tki-resistance"},{"display_name":"MET amplification","id":"met-amplification","score":0.6772,"url":"https://openalex.org/keywords/met-amplification"},{"display_name":"metastatic lung cancer","id":"metastatic-lung-cancer","score":0.2435,"url":"https://openalex.org/keywords/metastatic-lung-cancer"},{"display_name":"advanced lung cancer","id":"advanced-lung-cancer","score":0.2422,"url":"https://openalex.org/keywords/advanced-lung-cancer"},{"display_name":"EML4-ALK fusion","id":"eml4-alk-fusion","score":0.754,"url":"https://openalex.org/keywords/eml4-alk-fusion"}],"legacy_keywords":["EGFR Mutations","Targeted Therapy","ALK Inhibitors","Resistance Mechanisms","Clinical Trials","Genomic Profiling","Chemotherapy Regimens","Biomarker Analysis","Treatment Guidelines","Oncogene Addiction"],"openalex_id":"https://openalex.org/T10417","source_created_date":"2024-01-23T15:27:06","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2740","url":"/topics/T10417","works_api_url":"https://api.openalex.org/works?filter=topics.id:T10417","works_count":97623,"label":"Lung Cancer Treatments and Mutations","provider":"openalex","revision":"1dfc93fb4a071211","taxonomy_revision":"f050b5d4780b1289","title":"Lung Cancer Treatments and Mutations","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36240181364139306","address_version":"morton4x16-v1","coordinates":[4,27,2740,10417],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}